Oncogenic ras induces gastrin gene expression in colon cancer

被引:67
作者
Nakata, H
Wang, SL
Chung, DC
Westwick, JK
Tillotson, LG
机构
[1] Univ N Carolina, Dept Med, Div Digest Dis & Nutr, Chapel Hill, NC 27599 USA
[2] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[3] Signal Pharmaceut Inc, San Diego, CA USA
关键词
D O I
10.1016/S0016-5085(98)70085-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The expression of gastrin, as a tumor growth factor, is significantly increased in some colon cancers compared with the low levels found in normal mucosa. The aim of this study was to elucidate the transcriptional mechanisms of gastrin induction in colon cancer. Methods: Gastrin messenger (mRNA) levels and K-ras genotype were determined in colon cancer cell lines and surgical specimens. Colon cancer cells were transfected with oncogenic ras expression vectors, and transcriptional activity was assayed with gastrin-luciferase reporter genes. Results: Colon cancer cell lines and tissues with K-ras mutations all had significantly higher gastrin mRNA levels than those that were ras wild type. Treatment of several ras mutant cell lines with PD98059, an inhibitor of mitogen-activated protein kinase kinase, resulted in a decrease in endogenous gastrin mRNA levels. The effects of ras on gastrin expression appeared to be mediated through the gastrin promoter because transfection of oncogenic ras and activated raf expression vectors both induced gastrin-promoter, luciferase-reporter genes. The inductive effects of oncogenic ras could be blocked by the coexpression of dominant negative forms of raf and extracellular regulated kinase. Conclusions: Oncogenic ras induces gastrin gene expression through activation of the Raf-MEK-ERK signal transduction activation pathway.
引用
收藏
页码:1144 / 1153
页数:10
相关论文
共 66 条
[1]   GROWTH-FACTORS AND CANCER [J].
AARONSON, SA .
SCIENCE, 1991, 254 (5035) :1146-1153
[2]   REPORTER GENES - APPLICATION TO THE STUDY OF MAMMALIAN GENE-TRANSCRIPTION [J].
ALAM, J ;
COOK, JL .
ANALYTICAL BIOCHEMISTRY, 1990, 188 (02) :245-254
[3]  
Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4
[4]  
BALDWIN GS, 1992, CANCER RES, V52, P2261
[5]   ONCOGENES AND THE STRATEGY OF GROWTH-FACTORS [J].
BASERGA, R .
CELL, 1994, 79 (06) :927-930
[6]   PROGLUMIDE, A GASTRIN RECEPTOR ANTAGONIST, INHIBITS GROWTH OF COLON CANCER AND ENHANCES SURVIVAL IN MICE [J].
BEAUCHAMP, RD ;
TOWNSEND, CM ;
SINGH, P ;
GLASS, EJ ;
THOMPSON, JC .
ANNALS OF SURGERY, 1985, 202 (03) :303-309
[7]   PROGNOSTIC VALUE OF P53 OVEREXPRESSION AND C-KI-RAS GENE-MUTATIONS IN COLORECTAL-CANCER [J].
BELL, SM ;
SCOTT, N ;
CROSS, D ;
SAGAR, P ;
LEWIS, FA ;
BLAIR, GE ;
TAYLOR, GR ;
DIXON, MF ;
QUIRKE, P .
GASTROENTEROLOGY, 1993, 104 (01) :57-64
[8]  
BOEL E, 1983, P NATL ACAD SCI USA, V80, P286
[9]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[10]  
BRAND SJ, 1988, J BIOL CHEM, V263, P5341